Last update on our COVID-19 vaccine

Last update on our COVID-19 vaccine

It has been almost 7 months since the last update of our work on the COVID-19 vaccine candidate. In this post, we share the results and what we have learned. Because there are several other vaccines available that are highly effective against SARS-CoV-2, we decided to stop further research on our vaccine and to focus on developing cancer therapies. We will explain more about our decision in this post. First, a brief reminder on why we decided to make a…

Update on COVID19 vaccine

Update on COVID19 vaccine

We want to share exciting news: Lab results show that we have made our vaccine as designed. In our previous post, we disclosed a design of a potential vaccine for COVID-19 based on VSV. In a subsequent post, we have also shared quite a bit of scientific background on why we believe it should work. With this post, we want to share an update on our work in the lab. Before we do that a bit of background. The physical…

Introduction – Peter Weijmarshausen

Introduction – Peter Weijmarshausen

The third and last in a series of Questions and Answers with the co-founders of Humane Genomics. Q: Tell me a bit about yourself. I am a serial entrepreneur and one of the co-founders of Shapeways. I am a big tech and science nerd and have too many interests to keep up with. Some of the things I am passionate about, besides Humane Genomics, are: astrophysics, internet of things (Raspberry Pi’s), writing software in various different languages, brewing beer, cooking,…